BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18578034)

  • 1. Changes are recommended in use of nelfinavir.
    Wilcox RD
    HIV Clin; 2008; 20(1):1, 4. PubMed ID: 18578034
    [No Abstract]   [Full Text] [Related]  

  • 2. The Viracept (nelfinavir)--ethyl methanesulfonate case: a threshold risk assessment for human exposure to a genotoxic drug contamination?
    Lutz WK
    Toxicol Lett; 2009 Nov; 190(3):239-42. PubMed ID: 19695319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What happened: the chemistry side of the incident with EMS contamination in Viracept tablets.
    Gerber C; Toelle HG
    Toxicol Lett; 2009 Nov; 190(3):248-53. PubMed ID: 19857795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view.
    Müller L; Singer T
    Toxicol Lett; 2009 Nov; 190(3):243-7. PubMed ID: 19857794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Viracept-EMS case: impact and outlook.
    Walker VE; Casciano DA; Tweats DJ
    Toxicol Lett; 2009 Nov; 190(3):333-9. PubMed ID: 19866516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recall of AIDS drug hits world's poorest patients.
    AIDS Read; 2007 Sep; 17(9):439. PubMed ID: 17902224
    [No Abstract]   [Full Text] [Related]  

  • 8. In-utero exposure to nelfinavir-ethyl methyl sulfone.
    Hleyhel M; Goujon S; Sibiude J; Blanche S; Warszawski J;
    AIDS; 2016 Nov; 30(17):2729-2730. PubMed ID: 27662548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. New formulation of nelfinavir on the way.
    TreatmentUpdate; 2003; 15(3):6. PubMed ID: 17216848
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug design: new inhibitors for HIV-1 protease based on Nelfinavir as lead.
    Perez MA; Fernandes PA; Ramos MJ
    J Mol Graph Model; 2007 Oct; 26(3):634-42. PubMed ID: 17459746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMS in Viracept--initial ('traditional') assessment of risk to patients based on linear dose response relations.
    Gocke E; Müller L; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):266-70. PubMed ID: 19439165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nelfinavir, a new protease inhibitor: early clinical results.
    Powderly WG; Tebas P
    AIDS; 1999 Sep; 13 Suppl 1():S41-8. PubMed ID: 10546784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caution regarding nelfinavir use in children and pregnant women.
    AIDS Clin Care; 2007 Nov; 19(11):96. PubMed ID: 18399001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cheap AIDS drugs for developing countries.
    de Boer J
    Trends Cell Biol; 2001 Nov; 11(11):450. PubMed ID: 11684423
    [No Abstract]   [Full Text] [Related]  

  • 15. Nelfinavir (Viracept).
    Res Initiat Treat Action; 2000 Mar; 6(1):30-1. PubMed ID: 11708185
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human.
    Lavé T; Birnböck H; Götschi A; Ramp T; Pähler A
    Toxicol Lett; 2009 Nov; 190(3):303-9. PubMed ID: 19695315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nelfinavir safe and effective in HIV/HCV patients.
    AIDS Patient Care STDS; 2003 Nov; 17(11):602-3. PubMed ID: 14750219
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term response for nelfinavir.
    AIDS Patient Care STDS; 2001 Sep; 15(9):495. PubMed ID: 11587636
    [No Abstract]   [Full Text] [Related]  

  • 19. Two possible pathways for acquisition of mutations related to nelfinavir resistance.
    Sugiura W; Oishi T; Okano A; Matsuda M; Abumi H; Yamada K; Koike M; Taki M; Ishikawa M; Miura T; Fukutake K; Gouchi K; Ajisawa A; Iwamoto A; Hanabusa H; Mimaya J; Takamatsu J; Takata N; Kakishita E; Higasa S; Kashiwagi S; Shirahata A; Nagai Y
    Jpn J Infect Dis; 1999 Aug; 52(4):175-6. PubMed ID: 10592904
    [No Abstract]   [Full Text] [Related]  

  • 20. Nelfinavir tolerated in HCV patients.
    AIDS Patient Care STDS; 2002 Dec; 16(12):617. PubMed ID: 12881882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.